Processa Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PCSA
CUSIP
74275C304
All holders as of
Q3 2025
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74275C304 since 12/18/2024, newest first.

Filer % of Class Filed
CVI Investments, Inc. 13G/A Amendment 2
9.0% 11/7/2025
Event 9/30/2025
Chiliz Group Ltd. 13D/A Amendment 1 10.9% 10/15/2025
Event 8/5/2025
CVI Investments, Inc. 13G/A Amendment 1
9.9% 8/14/2025
Event 6/30/2025
Armistice Capital, LLC 13G/A Amendment 1
4.99% 8/14/2025
Event 6/30/2025
HX Entertainment Ltd 13D 10.9% 8/13/2025
Event 8/5/2025
Intracoastal Capital LLC 13G/A Amendment 1
10.0% 8/12/2025
Event 6/30/2025
CVI Investments, Inc. 13G
9.9% 6/24/2025
Event 6/17/2025
3i, LP 13G
4.9% 6/23/2025
Event 6/17/2025
Intracoastal Capital LLC 13G
10.0% 6/23/2025
Event 6/17/2025
Armistice Capital, LLC 13G
10.0% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 14 1.78 M $342 k
2025 Q2 14 373 k $75.9 k
2025 Q1 10 171 k $63.2 k
2024 Q4 9 98.9 k $87.5 k
2024 Q3 9 48.6 k $66.5 k
2024 Q2 10 45.0 k $101 k
2024 Q1 12 106 k $251 k